Pfizer Wins Obesity Drug Prize, With Trump Administration Assist

Published on November 10, 2025

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he learned he’d finally claimed his prize.

Continue reading on website
Other news

ETFs Outpace Last Year’s Inflows & They’re Not Done

November 10, 2025
When it comes to inflows, it seems like ETFs are content with beating themselves. After a record 2024 that saw inflows amass just under $1.14 trillion, ETFs did it again by edging past that level today. And they’re not done. State Street Investment Management is projecting total inflows could end the year at $1.4 trillion.

What Will Trump Buy Next? Hunt Is On for White House Stock Picks

November 10, 2025
Adam Giddens used to mainly rely on screening services and social-media buzz when looking for stocks to buy. Lately, though, he’s turned his attention to a different kind of influencer: Donald Trump.